Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1

Biochemistry (Moscow)

Volumn 80, Issue 3, 2015, Pages 276-283

  Xuan, Hanqing ^a   Xue, Wei ^a   Pan, Jiahua ^a   Sha, Jianjun ^a   Dong, Baijun ^a   Huang, Yiran ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Bmi 1; cell proliferation; miRNA; prostate cancer

Indexed keywords

BMI1 PROTEIN; BMI1 PROTEIN, HUMAN; MICRORNA; MIRN15 MICRORNA, HUMAN; MIRN221 MICRORNA, HUMAN; MIRN30 MICRORNA, HUMAN;

APOPTOSIS; CELL PROLIFERATION; DOWN REGULATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; POLYCOMB REPRESSIVE COMPLEX 1; PROSTATIC NEOPLASMS;

EID: 84925594979     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1134/S0006297915030037     Document Type: Article

References (13)

1. Siddique, H. R., and Saleem, M. (2012) Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences, Stem Cells, 30, 372-378.
2. Kang, M. K., Kim, R. H., Kim, S. J., Yip, F. K., Shin, K. H., Dimri, G. P., Christensen, R., Han, T., and Park, N. H. (2007) Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival, Brit. J. Cancer, 96, 126-133.
3. Atala, A. (2013) Re: Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, e3 ligase activity, and DNA damage repair activity in mouse prostate cancer, J. Urol., 189, 771.
4. Ammirante, M., Kuraishy, A. I., Shalapour, S., Strasner, A., Ramirez-Sanchez, C., Zhang, W., Shabaik, A., and Karin, M. (2013) An IKKalpha-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence, Genes Devel., 27, 1435-1440.
5. Lukacs, R. U., Memarzadeh, S., Wu, H., and Witte, O. N. (2010) Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation, Cell Stem Cell, 7, 682-693.
6. Wu, W. K., Lee, C. W., Cho, C. H., Fan, D., Wu, K., Yu, J., and Sung, J. J. (2010) MicroRNA dysregulation in gastric cancer: a new player enters the game, Oncogene, 29, 5761-5771.
7. Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S., and Calin, G. A. (2009) MicroRNAs - the micro-steering wheel of tumor metastases, Nature Rev. Cancer, 9, 293-302.
8. Srivastava, A., Goldberger, H., Dimtchev, A., Marian, C., Soldin, O., Li, X., Collins, S. P., Suy, S., and Kumar, D. (2014) Circulatory miR-628-5p is downregulated in prostate cancer patients, Tumor Biol. J. Int. Soc. Oncodevel. Biol. Med., 35, 4867-4873.
9. Qiang, X. F., Zhang, Z. W., Liu, Q., Sun, N., Pan, L. L., Shen, J., Li, T., Yun, C., Li, H., and Shi, L. H. (2014) miR-20a promotes prostate cancer invasion and migration through targeting ABL2, J. Cell. Biochem., 115, 1269-1276.
10. Ottman, R., Nguyen, C., Lorch, R., and Chakrabarti, R. (2014) MicroRNA expressions associated with progression of prostate cancer cells to anti-androgen therapy resistance, Mol. Cancer, 13, 1.
11. Bhattacharya, R., Nicoloso, M., Arvizo, R., Wang, E., Cortez, A., Rossi, S., Calin, G. A., and Mukherjee, P. (2009) MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer, Cancer Res., 69, 9090-9095.
12. Guo, S., Xu, X., Tang, Y., Zhang, C., Li, J., Ouyang, Y., Ju, J., Bie, P., and Wang, H. (2014) miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression, Cancer Lett., 344, 40-46.
13. Hoffmann, M. J., Engers, R., Florl, A. R., Otte, A. P., Muller, M., and Schulz, W. A. (2007) Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer, Cancer Biol. Ther., 6, 1403-1412.